Welcome to our dedicated page for CO news (Ticker: CO), a resource for investors and traders seeking the latest updates and insights on CO stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect CO's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of CO's position in the market.
Global Cord Blood Corporation (NYSE: CO) reported its fourth quarter fiscal 2020 results, showcasing a 19.2% increase in revenues to RMB299.9 million ($42.4 million), driven by 18,488 new subscribers, totaling 833,094 subscribers. Operating income surged 68.1% to RMB149.3 million ($21.1 million), and non-GAAP operating income rose 58.7% to RMB161.7 million ($22.8 million). However, net cash from operations fell 59.4% to RMB90.0 million ($12.7 million), impacted by COVID-19 challenges.
Global Cord Blood Corporation (NYSE: CO), China's top provider of cord blood services, will release its financial results for Q4 and full-year fiscal 2020 on June 29, 2020, post-market close. A conference call is scheduled for June 30, 2020, at 8:00 AM ET to discuss the financial performance and recent developments. Interested parties can listen via the IR website or by phone. The company's comprehensive services include cord blood collection, laboratory testing, and stem cell storage, enhancing its market leadership in China.